Emergence of class 1 integron-associated GES-5 and GES-5-like extended-spectrum β-lactamases in clinical isolates of Pseudomonas aeruginosa in South Africa

被引:44
作者
Labuschagne, Christiaan De J. [2 ,3 ]
Weldhagen, Gerhard F. [1 ]
Ehlers, Marthie M. [3 ]
Dove, Michael G. [3 ]
机构
[1] AMPATH Natl Lab Serv, Mol Biol Lab, ZA-0001 Pretoria, South Africa
[2] Inqaba Biotech Ind, Pretoria, South Africa
[3] Univ Pretoria, Fac Hlth Sci, Dept Med Microbiol, ZA-0002 Pretoria, South Africa
关键词
extended-spectrum beta-lactamase; ESBL; GES-5; Pseudomonas aeruginosa;
D O I
10.1016/j.ijantimicag.2008.01.020
中图分类号
R51 [传染病];
学科分类号
100401 [流行病与卫生统计学];
摘要
Several different Guiana extended-spectrum (GES) enzymes have been described occurring in Enterobacteriaceae and Pseudomonas aeruginosa worldwide. Polymerase chain reaction and gene sequencing analysis confirmed bla(GES) genes identified in three P. aeruginosa clinical isolates from South Africa as bla(GES-5) and bla(GES-5)-like, respectively. Compared with GES-1, the GES-5-like protein exhibited an A21E amino acid change, a novel mutation not previously described in this family. Integron structures identified upstream from the bla(GES-5) and bla(GES-5)-like genes were found to be identical to bla(GES-2)-carrying integrons described previously from the same geographical region. These findings confirm the establishment and persistence of integron-associated GES-type extended-spectrum beta-lactamases(ESBLs) in the South African nosocomial environment. This study describes the first isolation of class 1 integron-associated bla(GES-5) and the emergence of a novel GES-5-like ESBL in South Africa. (c) 2008 Published by Elsevier B. V. and the International Society of Chemotherapy.
引用
收藏
页码:527 / 530
页数:4
相关论文
共 18 条
[1]
[Anonymous], 2006, METH DIL ANT SUSC TE
[2]
First outbreak of Klebsiella pneumoniae clinical isolates producing GES-5 and SHV-12 extended-spectrum β-lactamases in Korea [J].
Jeong, SH ;
Bae, IK ;
Kim, D ;
Hong, SG ;
Song, JS ;
Lee, JH ;
Lee, SH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (11) :4809-4810
[3]
OXA-18, a class D clavulanic acid-inhibited extended-spectrum beta-lactamase from Pseudomonas aeruginosa [J].
Philippon, LN ;
Naas, T ;
Bouthors, AT ;
Barakett, V ;
Nordmann, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (10) :2188-2195
[4]
Biochemical sequence analyses of GES-1, a novel class A extended-spectrum β-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae [J].
Poirel, L ;
Le Thomas, I ;
Naas, T ;
Karim, A ;
Nordmann, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (03) :622-632
[5]
Integron-encoded GES-type extended-spectrum β-lactamase with increased activity toward aztreonam in Pseudomonas aeruginosa [J].
Poirel, L ;
Brinas, L ;
Fortineau, N ;
Nordmann, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (08) :3593-3597
[6]
A nosocomial outbreak of Pseudomonas aeruginosa isolates expressing the extended-spectrum β-lactamase GES-2 in South Africa [J].
Poirel, L ;
Weldhagen, GF ;
De Champs, C ;
Nordmann, P .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 49 (03) :561-565
[7]
GES-2, a class A β-lactamase from Pseudomonas aeruginosa with increased hydrolysis of imipenem [J].
Poirel, L ;
Weldhagen, GF ;
Naas, T ;
De Champs, C ;
Dove, MG ;
Nordmann, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (09) :2598-2603
[8]
Novel GES/IBC extended-spectrum β-lactamase variants with carbapenemase activity in clinical enterobacteria [J].
Vourli, S ;
Giakkoupi, P ;
Miriagou, V ;
Tzelepi, E ;
Vatopoulos, AC ;
Tzouvelekis, LS .
FEMS MICROBIOLOGY LETTERS, 2004, 234 (02) :209-213
[9]
Characterization of In111, a class 1 integron that carries the extended-spectrum β-lactamase gene blaIBC-1 [J].
Vourli, S ;
Tzouvelekis, LS ;
Tzelepi, E ;
Lebessi, E ;
Legakis, NJ ;
Miriagou, V .
FEMS MICROBIOLOGY LETTERS, 2003, 225 (01) :149-153
[10]
Nosocomial spread of ceftazidime-resistant Klebsiella pneumoniae strains producing a novel class A β-lactamase, GES-3, in a neonatal intensive care unit in Japan [J].
Wachino, J ;
Doi, Y ;
Yamane, K ;
Shibata, N ;
Yagi, T ;
Kubota, T ;
Ito, H ;
Arakawa, Y .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (06) :1960-1967